Truist Financial
GILD icon

Truist Financial’s Gilead Sciences GILD Stock Holding History

Truist Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,800
Closed -$493K – 2585
2020
Q3 		$493K Buy
+7,800
New +$541K ﹤0.01% 1742

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Truist Financial's GILD Position: Q2 2026 in Review

Truist Financial reduced its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, selling an estimated $506K and leaving 272,022 shares worth $34.4M. The position accounts for 0.04% of the portfolio, ranked #323.

Truist Financial first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $96.8M in Q4 2019. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Truist Financial held 272,022 shares of Gilead Sciences worth $34.4M as of Q2 2026.
  • Truist Financial sold 3,844 Gilead Sciences shares in Q2 2026, an estimated $506K.
  • Gilead Sciences made up 0.04% of Truist Financial's portfolio in Q2 2026, its #323 holding.
  • Truist Financial first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Truist Financial's Gilead Sciences position peaked at $96.8M in Q4 2019.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.